Clinical Trial Update: The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer [NA]

View source ↗

Summary

The RIOT trial evaluating prehabilitation to reduce frailty and improve outcomes in pancreatic, liver, and gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Liver Cancer
• Pancreatic Cancer

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Adult Liver Carcinoma, Gastric Carcinoma | NA | Status: COMPLETED